- XL RB1/DLEU/
LAMP (Deletion Probe, D-5070-100-TC) - XA 13/21 (Aneusomy Probe, D-5602-100-OG)
- XA AneuScore I (Aneusomy Probe, D-5604-100-TC)
- XA 13/18/21 (Aneusomy Probe, D-5607-100-TC)
- XA AneuScore II (Aneusomy Probe, D-5609-100-TC)
- XA AneuScore II (Aneusomy Probe, D-5609-500-TC)
- XA AneuScore I (Aneusomy Probe, D-5604-500-TC)
- XA AneuScore III (Aneusomy Probe, D-5613-100-TC)
- XA AneuScore III (Aneusomy Probe, D-5613-500-TC)
- XL Smith-Magenis/Miller-Dieker (Deletion Probe, D-5422-050-OG)
- Biclonal myelodysplastic syndrome involving six chromosomes and monoallelicloss of RB1 - A rare case. (found in: Publications)
- XL E2A (Break Apart Probe, D-5019-100-OG)
- XL BCR/ABL1 plus (Translocation/Dual Fusion Probe, D-5052-100-OG)
- XL DLEU/LAMP (Deletion Probe, D-5054-100-OG)
- XL DLEU/LAMP/12cen (Deletion/Enumeration Probe, D-5055-100-TC)
- XL DLEU/TP53 (Deletion Probe, D-5067-100-OG)
- XL RARA BA (Break Apart Probe, D-5087-100-OG)
- Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. (found in: Publications)
- Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. (found in: Publications)
Please select your country of residence. Choose International if your country is not listed.
Our internet site may contain information that is not approved in all countries or regions. To ensure accuracy of content, it is required that you select the site which is appropriate for your country of residence.